Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.750
+0.030 (1.74%)
At close: Nov 25, 2025, 4:00 PM EST
1.740
-0.010 (-0.57%)
After-hours: Nov 25, 2025, 5:06 PM EST
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $48.97 million as of November 25, 2025. Its market cap has decreased by -85.61% in one year.
Market Cap
48.97M
Enterprise Value
-223.93K
1-Year Change
-85.61%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $48.97M, a decrease of -60.10%. That is a compound annual growth rate of -14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 48.13M | -84.99% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |